Education
About Us
Working with TipRanks
Follow Us
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
Total Valuation
OptimizeRx has a market cap or net worth of $110.54M. The enterprise value is $113.28M.
Market Cap$110.54M
Enterprise Value$113.28M
Share Statistics
OptimizeRx has 18,640,652 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,640,652
Owned by Insiders9.72%
Owned by Institutions23.01%
Financial Efficiency
OptimizeRx’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 5.56%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.56%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee854.91K
Profits Per Employee40.09K
Employee Count128
Asset Turnover0.62
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OptimizeRx is 44.3. OptimizeRx’s PEG ratio is -0.35.
PE Ratio44.3
PS Ratio2.08
PB Ratio1.77
Price to Fair Value1.77
Price to FCF12.19
Price to Operating Cash Flow5.91
PEG Ratio-0.35
Income Statement
In the last 12 months, OptimizeRx had revenue of 109.43M and earned 5.13M in profits. Earnings per share was 0.28.
Revenue109.43M
Gross Profit69.27M
Operating Income12.06M
Pretax Income6.95M
Net Income5.13M
EBITDA16.39M
Earnings Per Share (EPS)0.28
Cash Flow
In the last 12 months, operating cash flow was 18.71M and capital expenditures -58.00K, giving a free cash flow of 18.66M billion.
Operating Cash Flow18.71M
Free Cash Flow18.66M
Free Cash Flow per Share1.00
Dividends & Yields
OptimizeRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.13
52-Week Price Change-17.06%
50-Day Moving Average10.26
200-Day Moving Average14.36
Relative Strength Index (RSI)30.43
Average Volume (3m)490.14K
Important Dates
OptimizeRx upcoming earnings date is Apr 30, 2026, TBA (Confirmed).
Last Earnings DateMar 5, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
OptimizeRx as a current ratio of 3.04, with Debt / Equity ratio of 20.35%
Current Ratio3.04
Quick Ratio3.04
Debt to Market Cap0.11
Net Debt to EBITDA0.17
Interest Coverage Ratio2.28
Taxes
In the past 12 months, OptimizeRx has paid 1.82M in taxes.
Income Tax1.82M
Effective Tax Rate0.26
Enterprise Valuation
OptimizeRx EV to EBITDA ratio is 14.05, with an EV/FCF ratio of 12.34.
EV to Sales2.10
EV to EBITDA14.05
EV to Free Cash Flow12.34
EV to Operating Cash Flow12.30
Balance Sheet
OptimizeRx has $23.36M in cash and marketable securities with $26.10M in debt, giving a net cash position of -$2.74M billion.
Cash & Marketable Securities$23.36M
Total Debt$26.10M
Net Cash-$2.74M
Net Cash Per Share-$0.15
Tangible Book Value Per Share$0.90
Margins
Gross margin is 63.30%, with operating margin of 11.02%, and net profit margin of 4.69%.
Gross Margin63.30%
Operating Margin11.02%
Pretax Margin6.35%
Net Profit Margin4.69%
EBITDA Margin14.98%
EBIT Margin11.02%
Analyst Forecast
The average price target for OptimizeRx is $13.92, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$13.92
Price Target Upside134.74% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast24.19%
EPS Growth Forecast―